| Income Statement |
| Total Revenue | 185.25M |
|
| Revenues (USD) | 185.25M |
| Cost of Revenue | 68.19M |
| Gross Profit | 117.05M |
| Operating Expenses | 113.72M |
| Research and Development Expense | 29.51M |
| Selling, General and Administrative Expense | 84.21M |
| Operating Income | 3.33M |
| Interest Expense | 4.37M |
| Income Tax Expense | -134.00K |
| Net Income | 106.00K |
| Net Income Common Stock | 106.00K |
| Net Income Common Stock (USD) | 106.00K |
| Consolidated Income | 106.00K |
| Earning Before Interest & Taxes (EBIT) | 4.34M |
| Earning Before Interest & Taxes (USD) | 4.34M |
| Weighted Average Shares | 140.09M |
| Weighted Average Shares Diluted | 146.48M |
| Balance Sheet |
| Cash and Equivalents | 94.96M |
| Cash and Equivalents (USD) | 94.96M |
| Trade and Non-Trade Receivables | 57.00M |
| Current Assets | 209.81M |
| Property, Plant & Equipment Net | 72.49M |
| Total Assets | 662.82M |
| Debt Current | 49.58M |
| Total Debt | 370.94M |
| Current Liabilities | 192.86M |
| Debt Non-Current | 321.36M |
| Total Liabilities | 516.21M |
| Accumulated Retained Earnings (Deficit) | -886.07M |
| Accumulated Other Comprehensive Income | -6.20M |
| Shareholders Equity | 146.61M |
| Shareholders Equity (USD) | 146.61M |
| Assets Non-Current | 453.01M |
| Total Debt (USD) | 370.94M |
| Deferred Revenue | 36.88M |
| Goodwill and Intangible Assets | 333.96M |
| Liabilities Non-Current | 323.36M |
| Trade and Non-Trade Payables | 36.71M |
| Cash Flow |
| Depreciation, Amortization & Accretion | 8.00M |
| Net Cash Flow from Financing | 1.40M |
| Net Cash Flow / Change in Cash & Cash Equivalents | 6.76M |
| Capital Expenditure | -3.16M |
| Net Cash Flow - Business Acquisitions and Disposals | -4.76M |
| Issuance (Purchase) of Equity Shares | 1.60M |
| Net Cash Flow from Investing | -7.92M |
| Net Cash Flow from Operations | 14.39M |
| Effect of Exchange Rate Changes on Cash | -1.10M |
| Share Based Compensation | 4.50M |